|
|
|
|
|
The risk factors for carbapenem-resistance of klebsiella pneumoniae isolated from lower respira-
tory tract in ICU |
ZHANG Bei- lei,LIN Jian- dong,LIAO Xiu- yu,CHEN Xiao- li |
Department of ICU,The First Affiliated Hospital of Fujian Medical University,Fuzhou 350005,China |
|
|
Abstract Objective To investigate the antibiotic resistance of klebsiella pneumoniae isolated from lower
respiratory tract in ICU and the risk factors of carbapenem-resistant,so as to provide reference
for making preventive and control measures of carbapenem-resistant klebsiella pneumoniae(CRKP)
infection. Methods The klebsiella pneumoniae isolated from sputum samples of patients with lower
respiratory tract infection from April 2013 to April 2015 in ICU were cultured to analyze the drug
resistance and clinical data of those patients who were collected to analyze the risk factors of
CRKP infection. Results ①The sensitive rate of Amikacin was the highest,which accounted for
86.81%,followed by imipenem and meropenem which accounted for 62.5% and 62.86%,respectively. Of 153 strains of isolated klebsiella pneumonia,56(36.7%)were CRKP. Among the CRKP isolated,the sensitive rate of Amikacin was the highest,which accounted for 68.52%,followed by cotrimoxazole,which accounted for 25%. The resistant rates of other antimicrobial agents were less than 20%. The resistance was very serious.②Univariate analysis revealed that length of hospital stay≥5 days,ICU
occupancy≥7 days,the length of mechanical ventilation≥7 days,use of urinary catheterization,use of Carbapenem antibiotics within 2 weeks,WBC>10.0×109/L or<4.0×109/L,the presence of fungal
infection at the same time and hypertension were risk factors for carbapenem-resistant. Logistic
regression analysis revealed that length ofhospital stay≥5 days and use of carbapenem antibiotics
within 2 weeks were independent risk factors for CRKP infection. Conclusion The resistance of
klebsiella pneumoniae was very serious in ICU.Reducing the use of carbapenem antibiotics and
shortening the length of hospital stay may help to prevent the lower respiratory tract infections
caused by CRKP.
|
Received: 03 August 2015
|
About author:: ZHANG Bei-lei, E-mail: rosensand7@aliyun.com |
|
|
|
[1] 医院感染诊断标准(试行). 中华医学杂志,2001,5:61-67.
[2] 胡付品,朱德妹,汪复,等. 2013 年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗杂志,2014,14(5):365-374.
[3] Hidron AI,Edwards JR,Patel J,et al. NHSN annual update: antimicrobial-resistant pathogens associated
with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety
Network at the Centers for Disease Control and Prevention,2006-2007[J]. Infect Control Hosp Epidemiol,2008,29(11):996-1011.
[4] Qi Y,Wei Z,Ji S,et al. ST11,the dominant clone of KPC-producing Klebsiella pneumoniae in China[J].
J Antimicrob Chemother,2011,66(2):307-312.
[5] 费东生,曹延会,南川川,等. 耐碳青霉烯类抗菌药物肺炎克雷伯菌呼吸机相关性肺炎的危险因素[J]. 中国老年学杂志,2014,
21:5973-5976.
[6] Felmingham RNG. The Alexander Project 1996- 1997: latest susceptibility data from this international
study of bacterial pathogensfrom community- acquired lower respiratory tract infections[J]. J Antimicrob
Chemother,2000,45(2):191-203.
[7] Bratu S,Landman D,Haag R,et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York
City: a new threat to our antibiotic armamentarium[J]. Arch Intern Med,2005,165(12):1430-1435.
[8] 吴文娟,张友祥,卢洪洲. 真菌定植与感染的认识[J]. 诊断学理论与实践,2009,5:481-483.
[9] 杨慧,向平超,郭伟安,等. RICU 多重耐药菌的耐药及危险因素分析[J]. 中国呼吸与危重监护杂志,2010,9(1):19-22.
[10] Carling PC,Briggs J,Hylander D,et al. An evaluation of patient area cleaning in 3 hospitals using a
novel targeting methodology[J].Am J Infect Control,2006,34(8):513-519.
[11] Stout JE,Muder RR,Mietzner S,et al. Role of environmental surveillance in determining the risk of
hospital-acquired legionellosis:a national surveillance study with clinical correlations[J]. Infect Control
Hosp Epidemiol,2007,28(7):818-824.
[12] Hussein K,Sprecher H,Mashiach T,et al. Carbapenem resistance among Klebsiella pneumoniae isolates:
risk factors,molecular characteristics,and susceptibility patterns[J]. Infect Control Hosp Epidemiol,
2009,30(7):666-671. |
|
|
|